APCs particularly dendritic cells (DC) sample antigens from tumor cells and present antigens to CD4+ T cells via the MHC class-II pathway or to CD8+ T-cells via cross presentation or cross priming [83, 84]. This evidence concerns the gene CD8A and neoplasm.